Joseph M. Coney, MD, FACS, explores strategies to address treatment obstacles among vulnerable patients and examines the effects of step therapy and prior authorization within a complex health care ...

Kim Albin has lost count of the number of times she’s had to battle health insurance companies over medications. Albin, who has been living with multiple sclerosis for nearly 30 years, said health ...

Please provide your email address to receive an email when new articles are posted on . Step therapy, a controversial payer policy, can cause treatment delays and contribute to physician burnout.

Young adults with IBD are more likely to face step therapy mandates, making clinicians concerned that insurers are ignoring evidence-based guidelines and imperiling outcomes.

Of the two components highlighted in Illinois’ legislation last week, the state’s ban on step therapy is “a lot more interesting,” according to David Shillcutt, attorney and member of the firm at ...

Panelists discuss how step-therapy for immunoglobulin A (IgA) nephropathy is evolving toward a more personalized approach, starting with optimized supportive care before progressing to targeted ...

Patient advocacy groups, patients and healthcare providers are praising Tennessee lawmakers and Governor Bill Lee for a bill to reform an insurance practice known as “step therapy.” The law will help ...

Insurers limit the use of certain prescription drugs by requiring step therapy—that is, by allowing access only after alternatives have been tried and have failed. Using data from seventeen of the ...